FDA Amends Notice for Pediatric Advisory Committee and Endocrinologic and Metabolic Drugs Advisory Committee Meeting

Summary

The US Food and Drug Administration (FDA) is updating the agenda for its Pediatric Advisory Committee (PAC) and Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) meeting, which was originally announced on January 23, 2018, to reflect changes in the open session and extend the closed session duration.